摘要
Abstract
Copeptin is a newbiomarker,numerous studies have shown its value of early diagnosis and prognosis in cadiovascular disease,lung infection and critical disease. The latest research shows important value of useing copeptin combined with tropnin for rapid rule out and diagnose of acute coronary syndrome,thereby reducing the waste of emergency resources,and benifiting patients with non-ST segment elevation myrocardial infaction. In this paper,recent research progress of useing copeptin as a biomarker for early diagnose of acute coronary syndrome are reviewd.关键词
和肽素/急性冠脉综合征/排阴/早期诊断Key words
Copeptin/Acute coronary syndrome/Rapid rule out/Early diagnosis
